Cargando…
Patently innovative : how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs /
Patently innovative provides a review of the importance of traditional patent law and emerging linkage regulations for pharmaceutical products on the global stage, with a focus on the linkage regime in Canada. The primary focus is on how innovation in the pharmaceutical sector can be strongly regula...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Oxford :
Biohealthcare,
2012.
|
| Colección: | Biohealthcare Publishing series on pharma, biotech and biosciences ;
13 |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ma 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn823041381 | ||
| 003 | OCoLC | ||
| 005 | 20231117044821.0 | ||
| 006 | m o d | ||
| 007 | cr |n||||||||| | ||
| 008 | 121231s2012 enka obj 001 0 eng d | ||
| 040 | |a YDXCP |b eng |e pn |c YDXCP |d OCLCO |d E7B |d N$T |d OPELS |d OCLCF |d OCLCQ |d OCLCO |d OCLCQ |d U3W |d D6H |d OTZ |d WYU |d CASUM |d OCLCO |d OCLCA |d S2H |d OCLCO |d OCLCQ |d OCLCO | ||
| 019 | |a 1066021427 | ||
| 020 | |a 1908818085 |q (electronic bk.) | ||
| 020 | |a 9781908818089 |q (electronic bk.) | ||
| 020 | |z 9781907568121 |q (hbk.) | ||
| 020 | |z 1907568123 |q (hbk.) | ||
| 035 | |a (OCoLC)823041381 |z (OCoLC)1066021427 | ||
| 050 | 4 | |a K1519.D78 |b B68 2012 | |
| 060 | 0 | 0 | |a 2012 B-185 |
| 060 | 1 | 0 | |a QV 736 |
| 072 | 7 | |a LAW |x 068000 |2 bisacsh | |
| 082 | 0 | 4 | |a 343.0786151 |2 22 |
| 100 | 1 | |a Bouchard, Ron A. | |
| 245 | 1 | 0 | |a Patently innovative : |b how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs / |c Ron A. Bouchard. |
| 260 | |a Oxford : |b Biohealthcare, |c 2012. | ||
| 300 | |a 1 online resource (xx, 275 pages) : |b illustrations. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Biohealthcare Publishing series on pharma, biotech and biosciences ; |v 13 | |
| 504 | |a Includes bibliographical references and index. | ||
| 520 | |a Patently innovative provides a review of the importance of traditional patent law and emerging linkage regulations for pharmaceutical products on the global stage, with a focus on the linkage regime in Canada. The primary focus is on how innovation in the pharmaceutical sector can be strongly regulated and how government regulation can either stimulate or inhibit development of breakthrough products. Includes empirical research to relate innovation to drug lawA multidisciplinary approach is taken, including the intersection of IP (intellectual property) law, drug law and innovationDiscusses the impact of government regulation on firm innovation. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Background : drug approval, drug patenting, pharmaceutical linkage and public health policy -- Empirical analysis of drug approval -- Empirical analysis of pharmaceutical innovation and drug approval-drug patenting linkage -- Empirical analysis of drug patenting in multiple high-value cohorts -- ?Implications of empirical data : are pharmaceutical linkage regulations a success? -- Future directions : testable hypotheses and evolution toward global pharmaceutical linkage. | |
| 650 | 0 | |a Drugs |v Patents. | |
| 650 | 0 | |a Patent extensions. | |
| 650 | 0 | |a Drug development. | |
| 650 | 1 | 2 | |a Patents. |
| 650 | 2 | 2 | |a Drug Approval |x economics |0 (DNLM)D017277Q000191 |
| 650 | 2 | 2 | |a Drug Industry |x legislation & jurisprudence |0 (DNLM)D004345Q000331 |
| 650 | 2 | 2 | |a Legislation, Drug |0 (DNLM)D007880 |
| 650 | 6 | |a M�edicaments |0 (CaQQLa)201-0002990 |v Brevets d'invention. |0 (CaQQLa)201-0378313 | |
| 650 | 6 | |a Brevets d'invention |x Prolongation de la dur�ee. |0 (CaQQLa)201-0267503 | |
| 650 | 6 | |a M�edicaments |x D�eveloppement. |0 (CaQQLa)201-0306620 | |
| 650 | 7 | |a LAW |x Military. |2 bisacsh | |
| 650 | 7 | |a Drug development |2 fast |0 (OCoLC)fst00898670 | |
| 650 | 7 | |a Drugs |2 fast |0 (OCoLC)fst00898761 | |
| 650 | 7 | |a Patent extensions |2 fast |0 (OCoLC)fst01054820 | |
| 655 | 7 | |a patents. |2 aat |0 (CStmoGRI)aatgf300027832 | |
| 655 | 7 | |a Patents |2 fast |0 (OCoLC)fst01423842 | |
| 655 | 7 | |a Patents. |2 lcgft | |
| 655 | 7 | |a Brevets d'invention. |2 rvmgf |0 (CaQQLa)RVMGF-000001468 | |
| 776 | 0 | 8 | |i Print version: |z 9781907568121 |z 1907568123 |w (DLC) 2011291446 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9781907568121 |z Texto completo |